Rani Therapeutics Ownership | Who Owns Rani Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Rani Therapeutics Ownership Summary

Rani Therapeutics is owned by 17.66% institutional investors, 19.56% insiders, and 62.78% retail investors. Armistice capital is the largest institutional shareholder, holding 8.62% of RANI shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.29% of its assets in Rani Therapeutics shares.

RANI Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Rani Therapeutics	17.66%	19.56%	62.78%
Sector	Healthcare Stocks	488.30%	11.08%	-399.38%
Industry	Biotech Stocks	307.10%	11.11%	-218.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Armistice capital	3.15M	8.62%	$1.62M
Vanguard group	709.83K	2.46%	$972.47K
Nan fung group	493.58K	1.35%	$253.65K
United services automobile association	302.74K	1.05%	$414.76K
Geode capital management	171.57K	0.59%	$235.11K
Takeda pharmaceutical	203.19K	0.56%	$104.42K
Kestra private wealth services	156.14K	0.43%	$80.24K
Cwa asset management group	150.00K	0.41%	$74.97K
Bank of america corp /de/	91.85K	0.35%	$349.01K
Blackrock funding, inc. /de	118.65K	0.32%	$60.98K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Takeda pharmaceutical	203.19K	0.53%	$104.42K
Nan fung group	493.58K	0.40%	$253.65K
Lasry marc	62.89K	0.18%	$32.32K
Armistice capital	3.15M	0.03%	$1.62M
United services automobile association	302.74K	0.01%	$414.76K
Insigneo advisory services	47.50K	0.01%	$65.08K
Well done	52.01K	0.01%	$26.73K
Islay capital management	9.61K	0.00%	$4.94K
Act advisors, llc.	14.81K	0.00%	$7.40K
Cwa asset management group	150.00K	0.00%	$74.97K

Top Buyers

Holder	Shares	% Assets	Change
Armistice capital	3.15M	0.03%	3.15M
Cwa asset management group	150.00K	0.00%	66.67K
Blackrock funding, inc. /de	118.65K	-	55.07K
Well done	52.01K	0.01%	52.01K
Insigneo advisory services	47.50K	0.01%	47.50K

Top Sellers

Holder	Shares	% Assets	Change
Alphabet	-	-	-448.49K
Two sigma investments, lp	-	-	-291.38K
Two sigma advisers, lp	-	-	-110.16K
Virtu financial	-	-	-45.40K
Alpha square group s	-	-	-33.40K

New Positions

Holder	Shares	% Assets	Change	Value
Armistice capital	3.15M	0.03%	3.15M	$1.62M
Well done	52.01K	0.01%	52.01K	$26.73K
Insigneo advisory services	47.50K	0.01%	47.50K	$65.08K
Act advisors, llc.	14.81K	0.00%	14.81K	$7.40K
Raymond james financial	2.95K	-	2.95K	$1.52K

Sold Out

Holder	Change
Qube research	-3.00
Wells fargo & company/mn	-103.00
Citigroup	-313.00
Belvedere trading	-991.00
Tower research capital llc (trc)	-1.72K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	40	-	6,453,465	89.46%	17	17.02%	10	-23.08%	10	66.67%
Mar 31, 2025	41	-6.82%	3,609,389	-5.48%	10	6.16%	13	-38.10%	6	20.00%
Dec 31, 2024	44	33.33%	3,818,467	-35.40%	13	3.15%	21	61.54%	5	-
Sep 30, 2024	32	-11.11%	5,707,881	97.28%	19	16.03%	13	8.33%	4	-42.86%
Jun 30, 2024	36	-2.70%	2,893,303	-7.12%	11	7.45%	12	-	7	40.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	507.61K	1.29%	-11.09K
Vanguard Institutional Extnd Mkt Idx Tr	180.55K	0.46%	-82.27K
Tema Obesity & Cardiometabolic ETF	105.60K	0.32%	-
Fidelity Extended Market Index	96.55K	0.20%	-680.00
Bridgeway Ultra-Small Company Market	46.50K	0.12%	-
iShares Micro-Cap ETF	50.13K	0.10%	-
Spartan Extended Market Index Pool E	22.45K	0.07%	7.55K
Fidelity Series Total Market Index	26.83K	0.06%	-
BlackRock Extended Equity Market K	16.40K	0.06%	-7.00
Fidelity Total Market Index	26.09K	0.05%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Oct 20, 2025	South Cone Investments Limited Partnership	-	Sell	$4.64M
Oct 21, 2025	South Cone Investments Limited Partnership	-	Sell	$11.07M
Dec 13, 2024	McKinley Kate	Chief Business Officer	Buy	$29.99K
Dec 09, 2024	Imran Talat	Chief Executive Officer	Buy	$19.97K
Oct 15, 2024	South Cone Investments Limited Partnership	-	Sell	$8.44M

Insider Transactions Trends

Date	Buy	Sell
2025 Q4	-	2
2025 Q3	-	-
2025 Q2	-	-
2024 Q4	2	2
2024 Q2	-	-

RANI Ownership FAQ

Who Owns Rani Therapeutics?

Rani Therapeutics shareholders are primarily institutional investors at 17.66%, followed by 19.56% insiders and 62.78% retail investors. The average institutional ownership in Rani Therapeutics's industry, Biotech Stocks , is 307.10%, which Rani Therapeutics falls below.

Who owns the most shares of Rani Therapeutics?

Rani Therapeutics’s largest shareholders are Armistice capital (3.15M shares, 8.62%), Vanguard group (709.83K shares, 2.46%), and Nan fung group (493.58K shares, 1.35%). Together, they hold 12.44% of Rani Therapeutics’s total shares outstanding.

Does Blackrock own Rani Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Rani Therapeutics.

Who is Rani Therapeutics’s biggest shareholder by percentage of total assets invested?

Takeda pharmaceutical is Rani Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.53% of its assets in 203.19K Rani Therapeutics shares, valued at 104.42K$.

Who is the top mutual fund holder of Rani Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Rani Therapeutics shares, with 1.29% of its total shares outstanding invested in 507.61K Rani Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools